GE Healthcare, State Company Russian Technologies and Medical Technologies Ltd jointly presented Russia’s first domestic mass-production factory for advanced CT scanners to Russian Prime Minister Putin by live video feed last week.
The manufacturing facility outside Moscow is the result of a strategic partnership between GE Healthcare and MTL, announced in November 2009. This partnership delivered Russia’s first domestically assembled 16-slice CT, which was installed in Moscow City Hospital No 67. Other scanners from the facility have been installed in Moscow, Blagoveschensk in the far east of Russia, and Irkutsk in Siberia.
The manufacturing capacity of the facility will be up to 200 CT scanners per year by 2012 and is aimed at meeting the clinical requirements of the Russian federal programs targeted at reduction of mortality from cardiovascular disease, stroke and traffic accidents.
Vyacheslav Grischenko, the president and general manager of GE Healthcare Russia/CIS, said: “GE Healthcare aims to help Russian doctors provide the best quality of health services at a lower price and for a wider range Russian population. Localizing production of hi-tech medical equipment in Russia will help us support the modernization of Russian medical institutions with innovative yet affordable technologies. In SC Russian Technologies and MTL we have reliable and competent partners that meet GE’s global high standards, and we are proud of being the first to mass-produce CTs like these in Russia.”
In the second stage of the project, the partners will extend the product range of diagnostic equipment to include angiographs, MR scanners, ultrasound, digital X-ray, PET and nuclear medicine scanners and other medical equipment.
Today there are more than 100 16-slice GE Healthcare CT units installed in Russia, and nearly one million Russian patients undergo examination in GE Healthcare scanners every year. According to industry estimates, today’s total demand for CTs in Russia is in excess of 3,000 units to meet the needs of the Russian federal programs targeted at reducing mortality from cardiovascular disease, stroke and traffic accidents.